Skip to main content
Top
Literature
1.
2.
go back to reference Oba-Shinjo SM, Caballero OL, Jungbluth AA et al (2008) Cancer-testis (CT) antigen expression in medulloblastoma. Cancer Immunol 22(8):7 Oba-Shinjo SM, Caballero OL, Jungbluth AA et al (2008) Cancer-testis (CT) antigen expression in medulloblastoma. Cancer Immunol 22(8):7
3.
go back to reference Bao L, Dunham K, Lucas K (2011) MAGE-A1, MAGE-A3, and NY-ESO-1 can be upregulated on neuroblastoma cells to facilitate cytotoxic T lymphocyte-mediated tumor cell killing. Cancer Immunol Immunother 60(9):1299–1307CrossRefPubMed Bao L, Dunham K, Lucas K (2011) MAGE-A1, MAGE-A3, and NY-ESO-1 can be upregulated on neuroblastoma cells to facilitate cytotoxic T lymphocyte-mediated tumor cell killing. Cancer Immunol Immunother 60(9):1299–1307CrossRefPubMed
4.
go back to reference Krishnadas DK, Shapiro T, Lucas K (2013) Complete remission following decitabine/dendritic cell vaccine for relapsed neuroblastoma. Pediatrics 131(1):e336–341CrossRefPubMed Krishnadas DK, Shapiro T, Lucas K (2013) Complete remission following decitabine/dendritic cell vaccine for relapsed neuroblastoma. Pediatrics 131(1):e336–341CrossRefPubMed
Metadata
Title
Targeting cancer-testis antigens in recurrent pediatric brain tumors
Authors
Deepa K. Krishnadas
Fanqi Bai
Kenneth G. Lucas
Publication date
01-05-2015
Publisher
Springer US
Published in
Journal of Neuro-Oncology / Issue 1/2015
Print ISSN: 0167-594X
Electronic ISSN: 1573-7373
DOI
https://doi.org/10.1007/s11060-015-1765-6

Other articles of this Issue 1/2015

Journal of Neuro-Oncology 1/2015 Go to the issue